“Special Exemptions”: Should They Be Put on Trial?
نویسندگان
چکیده
منابع مشابه
Thirty-something million: should they be exceptions?
There are over 30 million people in the United States with disabilities or functional limitations (of which a major cause is aging), and this number is increasing. An examination of the role of human factors in addressing this population is presented which includes both special designs for disability/aging and the incorporation of disability/aging into mainstream human factors research and educ...
متن کاملQuantity discounts; how big should they be?
While most market-oriented pricing schemes include offers of quantity discounts, their size is generally decided on arbitrarily. This article discusses the various possible marketing objectives of quantity discounts and argues that valid methods for calculating appropriate schedules should be linked to these objectives. Using a specific case study, the practical application of this approach is ...
متن کاملAntibiotic combinations: should they be tested?
When antibiotic combinations are used to provide a broader spectrum of antimicrobial activity or in an attempt to prevent the emergence of resistant organisms, it is rarely necessary or practical to perform tests of drug interactions in vitro. In vitro testing of combinations may be useful when combinations are used in an attempt to attain synergistic interactions. In some cases, screening meth...
متن کاملPelvic ring fractures: should they be fixed?
The management of traumatic disruption of the pelvic ring has become a focus of interest, the main question being whether such disruptions should be stabilised at operation. Stabilisation may be important for the survival of the patient, as has been suggested for femoral fractures, and it may also be desirable to improve the long-term functional results of such injuries. It is therefore necessa...
متن کاملCancer antigens: how specific should they be?
INTRODUCTION Four years have passed since the last comprehensive meeting was held to discuss directions in which the immunological discipline might contribute to an understanding of cancer problems, and it should be a measure of our progress to compare the content of the papers presented at that meeting with those delivered here. The earlier meeting did not have precisely the same objectives as...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Therapy
سال: 2013
ISSN: 1525-0016
DOI: 10.1038/mt.2013.1